The mRNA and/or protein levels of UBE2C are aberrantly enhanced in pancreatic cancer with dismal clinical outcomes (Shi et al. 2020; Zhu et al. 2021). This evidence concerns the gene UBE2C and familial pancreatic carcinoma.